suma/diarrhea

TECHNICAL FIELD The present invention relates to a therapeutic or prophylactic agent for functional bowel disorders, comprising as an effective ingredient a morphinan derivative having a nitrogen-containing cyclic substituent or a pharmaceutically acceptable acid addition salt thereof, which is

FIELD OF INVENTION This invention relates to therapeutic agents and in particular to substituted benzothiophene compounds, more particularly a series of 3-phenylbenzo[b]thiophene compounds, which are valuable as antidiarrhoeal agents. BACKGROUND OF THE INVENTION Diarrhoea is one of the major causes

FIELD OF THE INVENTION The present invention relates to glucagon-like-peptide-2 (GLP-2) analogues and their medical use, for example in the prophylaxis or treatment of stomach and bowel-related disorders and for ameliorating side effects of chemotherapy and radiation therapy. BACKGROUND OF THE

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to compounds and methods for modulating chloride ion transport, and, more specifically, to antagonists and agonists of inositol polyphosphates. 2. Background Information All living organisms are made of

BACKGROUND OF THE INVENTION Cancer is a leading cause of death in the United States. For example in 1998, an estimated 185,000 men were diagnosed with prostate cancer, and more than 39,000 men died of the disease. See, S. H. Landis et al., CA Cancer J. Clin. 48, 6, 1998. Although survival rates for

BACKGROUND OF THE INVENTION Irritable bowel syndrome (IBS) is a common functional disorder of the bowel that has a pronounced effect on quality of life. A defining characteristic of IBS is abdominal discomfort or pain. The Rome II Diagnostic Criteria (a system for diagnosing functional

FIELD OF THE INVENTION This invention relates to the use of a composition containing extracts of Buddleja globosa Hope and pharmacologically accepted additives for the treatment or prevention of several gastrointestinal disorders, particularly those associated with patient treatment with

Throughout this application, various references are referred to within parentheses. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to describe more fully the state of the art to which this invention pertains. BACKGROUND OF THE

Throughout this application, various references are referred to within parentheses. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to describe more fully the state of the art to which this invention pertains. BACKGROUND OF THE

Throughout this application, various references are referred to within parentheses. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to describe more fully the state of the art to which this invention pertains. BACKGROUND OF THE

Throughout this application, various references are referred to within parentheses. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to describe more fully the state of the art to which this invention pertains. BACKGROUND OF THE

BACKGROUND OF THE INVENTION Alpha adrenergic receptors are plasma membrane receptors which are located in the peripheral and central nervous systems throughout the body. They are members of a diverse family of structurally related receptors which contain seven putative helical domains and transduce

Throughout this application, various references are referred to within parentheses. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to describe more fully the state of the art to which this invention pertains. BACKGROUND OF THE

FIELD OF THE INVENTION This invention describes two Lactobacillus strains isolated from human stools that have the unique property of blocking experimental Neonatal Necrotizing Enterocolitis (NEC). BACKGROUND OF THE INVENTION NEC is the most serious gastrointestinal disorder of premature infants and

FIELD OF THE INVENTION This invention relates generally to alleles of the human mu opioid receptor gene, along with products derived from such alleles. Also included herein are methods of diagnosing various susceptibilities using such alleles and determining treatment for certain diseases based upon